The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atacand 16 mg Tablets

16 milligram(s) Tablet

PCO Manufacturing Ltd.PPA0465/116/002

Main Information

Trade NameAtacand 16 mg Tablets
Active SubstancesCandesartan cilexetil
Strength16 milligram(s)
Dosage FormTablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/116/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA06 candesartan

Status

Authorised/WithdrawnAuthorised
Licence Issued06/02/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA 970/30/4.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan 16mg Tablets
Interchangeable List CodeIC0009-038-002
Interchangeable List DocumentPDF of Interchangeable List
« Back